中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
高能物理研究所 [507]
近代物理研究所 [213]
上海药物研究所 [172]
合肥物质科学研究... [162]
地理科学与资源研究... [99]
物理研究所 [98]
更多
采集方式
OAI收割 [2427]
iSwitch采集 [443]
内容类型
期刊论文 [2714]
会议论文 [143]
CNKI期刊论文 [4]
SCI/SSCI论文 [3]
预印本 [3]
EI期刊论文 [1]
更多
发表日期
2025 [23]
2024 [93]
2023 [111]
2022 [188]
2021 [228]
2020 [196]
更多
学科主题
Physics [47]
半导体物理 [26]
Astronomy... [17]
Chemistry [17]
Biochemis... [15]
Plant Sci... [15]
更多
筛选
浏览/检索结果:
共2870条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
BMAL1/PGC1a4-FNDC5/irisin axis impacts distinct outcomes of time-of-day resistance exercise
期刊论文
OAI收割
JOURNAL OF SPORT AND HEALTH SCIENCE, 2025, 卷号: 14, 页码: 23
作者:
Guo, Mingwei
;
Shen, Fei
;
Guo, Xiaozhen
;
Zhang, Jun
;
Ma, Ying
  |  
收藏
  |  
浏览/下载:102/0
  |  
提交时间:2025/04/01
Daily variance
Circadian
Muscle strength
Metabolic benefits
Resistance exercise
The Overview and Trial Observations of AIMS
期刊论文
OAI收割
RESEARCH IN ASTRONOMY AND ASTROPHYSICS, 2025, 卷号: 25, 期号: 7
作者:
Deng, Yuanyong
;
Wang, Dongguang
;
Hua, Jianwen
;
Xu, Songbo
;
Liang, Ming
  |  
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2025/07/14
Sun: infrared
methods: observational
instrumentation: spectrographs
Identification of RIPK3 as a target of flavonoids for anti-necroptosis in vitro
期刊论文
OAI收割
BIOORGANIC CHEMISTRY, 2025, 卷号: 161, 页码: 11
作者:
Xie, Hang
;
Li, Wanchen
;
Han, Xiaoyu
;
Li, Minjun
;
Zhao, Qiang
  |  
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2025/07/25
RIPK3
Inhibitors
Flavonoids
Co-crystal structure
Anti-necroptosis effect
Design, synthesis, and activity evaluation of indole derivatives as potential stabilizers for p53 Y220C
期刊论文
OAI收割
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2025, 卷号: 121, 页码: 9
作者:
Li, Linquan
;
Gu, Xi
;
Meng, Jingyi
;
Wen, Yiming
;
Yi, Jing
  |  
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2025/05/27
p53 Y220C
Synthesis
Structural modification
Drug design
Structural insights into the activation of the human prostaglandin E
2
receptor EP1 subtype by prostaglandin E
2
期刊论文
OAI收割
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2025, 卷号: 122, 期号: 20, 页码: 12
作者:
Meng, Xue
;
Li, Yang
;
Xu, Jiuyin
;
Wu, Kai
;
Hu, Wen
  |  
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2025/07/25
prostaglandin E2
EP1
receptor activation
PGE2 selectivity
Microbiota-shaped neutrophil senescence regulates sexual dimorphism in bladder cancer
期刊论文
OAI收割
NATURE IMMUNOLOGY, 2025, 卷号: 26, 期号: 5, 页码: 46
作者:
Zhu, Qingchen
;
Zhang, Guiheng
;
Cao, Ming
;
Huang, Huan
;
He, Dan
  |  
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2025/06/23
Cnidaria XIAP activates caspase-mediated cell death
期刊论文
OAI收割
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 卷号: 310, 页码: 10
作者:
Chen, Yuan
;
Wu, Meng
;
Yuan, Zihao
;
Wang, Qingyue
;
Xu, Hang
  |  
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2025/07/11
XIAP
Cnidaria
Jellyfish
Apoptosis
Caspase
Glabridin as a selective Kv2.1 inhibitor ameliorates DPN pathology by disrupting the Aβ/Kv2.1/JNK/NF-κB/NLRP3/p-Tau pathway
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2025, 页码: 17
作者:
Xu, Jia-wen
;
Ma, Lin
;
Xiang, Yu
;
Dai, Meng-qing
;
Li, Qiu-hui
  |  
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2025/05/27
diabetic peripheral neuropathy
glabridin
Kv2.1
dorsal root ganglia
Schwann cells
A beta/Kv2.1/NLRP3/p-Tau axis
A prominent oxygenation event in the late Mesoproterozoic broke the calm of the second half of the "Boring Billion"
期刊论文
OAI收割
PALAEOGEOGRAPHY PALAEOCLIMATOLOGY PALAEOECOLOGY, 2025, 卷号: 662, 页码: 13
作者:
Meng, Lin
;
Shi, Xiaoying
;
Zhou, Limin
;
Li, Jie
;
Liu, Wei
  |  
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2025/04/03
Ce anomaly
Mo isotope
Taizi Formation
Yemahe Formation
South China
I/(Ca plus Mg)
Design, Synthesis, and biological evaluation of 7H-Pyrrolo[2,3-d] pyrimidines as potent HPK1 kinase inhibitors
期刊论文
OAI收割
BIOORGANIC & MEDICINAL CHEMISTRY, 2025, 卷号: 119, 页码: 13
作者:
Wu, Feifei
;
Li, Huiyu
;
Li, Weiqiang
;
Zhang, Laishun
;
An, Qi
  |  
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2025/04/01
Optimization
Hematopoietic progenitor kinase 1
Inhibitor
Cancer immunotherapy